On April 22, 2026, President Trump responded to a Wall Street Journal editorial calling him a “sucker” on Iran, criticizing its stance on the Strait of Hormuz. Trump claimed Iran’s navy is “at the bottom of the sea” and defended his policies, emphasizing his opposition to Iran’s military actions. The exchange highlights ongoing tensions over Iran’s influence in the region.
IEA Chief Fatih Birol warned Thursday that the world faces the biggest energy security threat in history, amid ongoing tensions in Iran and the Strait of Hormuz. His comments highlight concerns over global energy supplies as geopolitical conflicts threaten stability, prompting urgent calls for energy resilience and strategic planning worldwide.
President Trump told reporters on April 20, "Don’t rush me" regarding Iran, as he extended a ceasefire indefinitely this week, avoiding a deadline. There is no clear indication of upcoming peace talks. Trump also issued a warning to small Iranian vessels in the Strait of Hormuz, highlighting ongoing tensions in the region.
Iran's Foreign Ministry spokesperson Esmaeil Baqaei accused the U.S. of promoting terrorism after President Trump shared a quote on Truth Social suggesting Iranians opposed to a peace deal should be killed. The incident occurred on April 18, 2026, highlighting escalating tensions between Iran and the U.S. amid ongoing diplomatic disputes.
Former Vice President Mike Pence criticized President Trump’s recent feud with the Pope, stating he would have advised Trump to "let the pope be the pope and you be the president." Pence, who served as Trump’s VP for 4.5 years, made these comments in an interview shared on April 19, 2026. The remarks highlight Pence’s stance on maintaining separation between church and state.
On April 18, 2026, President Trump announced a deal with Regeneron to voluntarily lower drug prices as part of the White House’s “most favored nation” plan. Regeneron committed to reducing costs for current and future medications, making it the last major manufacturer to join the initiative aimed at aligning U.S. drug prices with those in other developed countries.
JetBlue faces a class action lawsuit alleging it uses passengers’ personal data to set airfares through ‘dynamic surveillance pricing.’ The complaint claims JetBlue tracks user information without consent to adjust ticket prices, raising privacy concerns. The case highlights ongoing debates over data privacy and pricing practices in the airline industry.
